BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guido M, Sarcognato S, Sacchi D, Colloredo G. Pathology of idiopathic non-cirrhotic portal hypertension. Virchows Arch 2018;473:23-31. [DOI: 10.1007/s00428-018-2355-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; The International Liver Pathology Study Group. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition. Histopathology 2019;74:219-26. [DOI: 10.1111/his.13738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
2 Cannella R, Minervini MI, Rachakonda V, Bollino G, Furlan A. Liver stiffness measurement in patients with nodular regenerative hyperplasia undergoing magnetic resonance elastography. Abdom Radiol (NY) 2020;45:373-83. [PMID: 31834457 DOI: 10.1007/s00261-019-02367-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang S, Quan M, Li Y, Pan CQ, Xing H. Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty's Syndrome: A Case Report and Literature Review. Biomed Res Int 2020;2020:2618260. [PMID: 32714976 DOI: 10.1155/2020/2618260] [Reference Citation Analysis]
4 Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Seminars in Diagnostic Pathology 2019;36:395-403. [DOI: 10.1053/j.semdp.2019.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Liang J, Shi C, Dupont WD, Salaria SN, Huh WJ, Correa H, Roland JT, Perri RE, Washington MK. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 2021;34:592-602. [PMID: 32958831 DOI: 10.1038/s41379-020-00676-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res 2021;14:49-65. [PMID: 34007347 DOI: 10.14740/gr1376] [Reference Citation Analysis]
7 Kang JH, Kim DH, Kim SY, Kang HJ, Lee JB, Kim KW, Lee SS, Choi J, Lim YS. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI. Abdom Radiol (NY) 2021;46:1891-903. [PMID: 33095310 DOI: 10.1007/s00261-020-02831-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ikeda D, Tsushima T, Fukumoto A, Kuzume A, Tabata R, Terao T, Miura D, Narita K, Takeuchi M, Honma K, Matsue K. Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation. Leuk Lymphoma 2022;:1-4. [PMID: 35021928 DOI: 10.1080/10428194.2022.2027400] [Reference Citation Analysis]
9 Seo JW, Kim ES, Han MH, Kweon YO. Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease. Intest Res 2021;19:247-51. [PMID: 32610890 DOI: 10.5217/ir.2020.00016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kmeid M, Zuo C, Lagana SM, Choi WT, Lin J, Yang Z, Liu X, Westerhoff M, Fiel MI, Affolter K, Choi EK, Lee H. Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension. Diagn Pathol 2020;15:129. [PMID: 33097074 DOI: 10.1186/s13000-020-01049-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Mochel MC, Wojcik JB, Gowda M, Tye GW, Patel RM, Smith SC. Pediatric soft tissue neoplasms with BRAF activating mutations. Mod Pathol 2021. [PMID: 34117348 DOI: 10.1038/s41379-021-00852-4] [Reference Citation Analysis]
12 Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, Chen J, Srour SA, Bashir Q, Rondon G, Oran B, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Marin D, Khouri IF, Ciurea SO, Qazilbash MH, Rezvani K, Anderlini P, Andersson BS, Shpall EJ, Champlin RE, Popat UR. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 2020;4:1296-306. [PMID: 32236526 DOI: 10.1182/bloodadvances.2019000638] [Reference Citation Analysis]
13 Lv Y, Li K, He C, Luo B, Zhang B, Liu H, Wang Z, Guo W, Wang Q, Chen H, Bai W, Yuan X, Yu T, Li X, Yuan J, Han N, Zhu Y, Niu J, Xie H, Wang J, Chen L, Yin Z, Fan D, Li Z, Han G. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther. 2019;49:926-939. [PMID: 30820990 DOI: 10.1111/apt.15186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang X, Thomas C, Schiano TD, Thung SN, Ward SC, Fiel MI. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology 2020;76:959-67. [PMID: 31994248 DOI: 10.1111/his.14083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]